The high impact factor of the European Journal of Heart Failure is primarily driven by the publication of ESC guidelines, which receive approximately 10 times more citations than other top articles.
The European Journal of Heart Failure (EJHF) has reached a high impact factor making it one of the most important cardiology journals. I discuss herein what could be the main causes of such high ranking. Publication of the European Society of Cardiology guidelines for the diagnosis and treatment of acute and chronic heart failure has had the most important role with a number of citations, which has been approximately 10 times that of the other most cited articles of the same year. Other position statements, reviews, design papers, and research articles about landmark topics have given major contributions. With respect to the different clinical presentations, articles about heart failure with preserved ejection fraction and about advanced heart failure have gained many citations. Epidemiology, biomarkers, medical treatment, and devices have attracted most of the interest. In conclusion, being able to look ahead and to publish what is going to become important remains a major challenge. That of EJHF has been a success story, to date, and learning from the past may help to build upon this achievement.
Marco Metra (Wed,) conducted a editorial in Heart failure. The high impact factor of the European Journal of Heart Failure is primarily driven by the publication of ESC guidelines, which receive approximately 10 times more citations than other top articles.